Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0006675,
umls-concept:C0008051,
umls-concept:C0010453,
umls-concept:C0030685,
umls-concept:C0037663,
umls-concept:C0040162,
umls-concept:C0205225,
umls-concept:C0229535,
umls-concept:C0391871,
umls-concept:C0679823,
umls-concept:C0680255,
umls-concept:C1283071,
umls-concept:C1566942,
umls-concept:C1963578
|
pubmed:issue |
3
|
pubmed:dateCreated |
1989-11-14
|
pubmed:abstractText |
We previously reported that thyrotropin-releasing hormone (TRH) and human pancreatic growth hormone-releasing factor (hpGRF) exert synergistic (greater than additive) effects on growth hormone (GH) release from chicken pituitary cells in primary culture. In the present studies the possible participation of calcium in GH release and in TRH and hpGRF synergy was investigated. Following dispersion with collagenase, cells were cultured for 48 hr prior to exposure (2 hr) to test agents. Cultured cells were exposed to a range of calcium concentrations (0, 0.02, 0.2, and 2.0 mM) in the presence and absence of secretagogues. These results demonstrated that basal GH release was not altered by the concentration of calcium in the medium: however, secretagogue-induced GH release required calcium. Thus, TRH, hpGRF, 8 Br-cAMP, or forskolin stimulated GH release in the absence of calcium. Furthermore, synergistic GH release evoked by TRH and hpGRF, 8 Br-cAMP, or forskolin was observed only at the highest calcium concentration (2.0 mM). In other studies, ionomycin (10(-5) M), a calcium ionophore, stimulated GH release to a value about 125% over the basal (absence of test agent) value. Ionomycin-induced GH release was not affected by TRH (5.0 ng/ml); the combined effects of ionomycin (10(-7)-10(-5) M) and hpGRF (5.0 ng/ml) on GH release were less than additive. However, ionomycin (10(-5) M) further increased GH release over that resulting from the synergistic action of TRH and hpGRF (5.0 ng/ml each). Verapamil (a calcium channel blocker) did not affect GH release induced by either TRH or hpGRF (5.0 ng/ml each). However, this agent did inhibit synergistic GH release evoked by TRH and hpGRF, 8 Br-cAMP, forskolin, or isobutylmethylxanthine. These results suggest that calcium participates in secretagogue-induced GH release from chicken somatotrophs in vitro.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0016-6480
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
75
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
481-91
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:2507391-Animals,
pubmed-meshheading:2507391-Calcium,
pubmed-meshheading:2507391-Cells, Cultured,
pubmed-meshheading:2507391-Chickens,
pubmed-meshheading:2507391-Drug Synergism,
pubmed-meshheading:2507391-Growth Hormone-Releasing Hormone,
pubmed-meshheading:2507391-Male,
pubmed-meshheading:2507391-Pancreatic Hormones,
pubmed-meshheading:2507391-Pituitary Gland, Anterior,
pubmed-meshheading:2507391-Thyrotropin-Releasing Hormone
|
pubmed:year |
1989
|
pubmed:articleTitle |
Possible participation of calcium in growth hormone release and in thyrotropin-releasing hormone and human pancreatic growth hormone-releasing factor synergy in a primary culture of chicken pituitary cells.
|
pubmed:affiliation |
Department of Anatomy, UMDNJ-Robert Wood Johnson Medical School, Piscataway 08854.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|